Tax & Penalty19 Aug 2026, 05:30 pm
GSK Pharma Receives ₹4.99 Cr Tax Refund for AY 2025-2026
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd has received an intimation under Section 143(1) of the Income Tax Act, resulting in a tax refund of ₹4.99 Crores for the Assessment Year 2025-2026. The refund was credited to the company's bank account on August 18, 2026. This refund will be accounted for in the 'Tax Paid Assets' account on the company's balance sheet. No violations or contraventions were alleged.
Key Highlights
- Received tax refund of ₹4.99 Crores for AY 2025-2026.
- Refund credited on August 18, 2026.
- Intimation received under Section 143(1) of the Income Tax Act.
- Impact on balance sheet: accounted in Tax Paid Assets.
Price Impact
More from GLAXO